The Diagnostic Value of Irisin in Pediatric Patients with Acute Abdominal Pain

Fatma Sarac1, Sevgi Buyukbese Sarsu2, Selman Yeniocak3

  • 1Department of Pediatric Surgery, Haseki Research and Education Hospital, Istanbul, Turkey.

Insights

Irisin, a peptide hormone, shows potential as a biomarker for diagnosing acute appendicitis (AA) and perforated appendicitis (PA) in children. Elevated irisin levels help differentiate these conditions from other causes of acute abdominal pain.

Area of Science:

  • Pediatric Emergency Medicine
  • Gastroenterology
  • Biomarker Discovery

Background:

  • Diagnosing acute abdominal pain in pediatric patients presents clinical challenges.
  • Accurate differentiation is crucial for timely surgical intervention.

Purpose of the Study:

  • To evaluate the efficacy of irisin as a diagnostic biomarker.
  • To differentiate acute appendicitis (AA) and perforated appendicitis (PA) in children presenting with acute abdominal pain.

Main Methods:

  • A cohort of 112 pediatric patients with acute abdominal pain and 50 controls were enrolled.
  • Blood samples were analyzed for irisin, white blood cell (WBC) count, and C-reactive protein (CRP) levels.

Main Results:

  • Mean irisin levels were significantly higher in patients with AA and PA compared to controls and nonspecific abdominal pain.
  • WBC and CRP levels were also elevated in AA and PA cases.
  • No significant difference in irisin levels was found between AA and PA.

Conclusions:

  • Irisin may serve as a valuable biomarker in the differential diagnosis of acute abdominal pain in pediatric patients.
  • This can aid in distinguishing appendicitis from other abdominal conditions, potentially improving surgical decision-making.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
262
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
226
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
405
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
296
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
275